|
EPS15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.65474358846541E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.65152352799214E-12 |
| Normal-vs-Stage2 |
4.06649999995512E-06 |
| Normal-vs-Stage3 |
6.31449999999312E-05 |
| Normal-vs-Stage4 |
9.200200E-02 |
| Stage1-vs-Stage2 |
4.779000E-01 |
| Stage1-vs-Stage3 |
4.466400E-01 |
| Stage1-vs-Stage4 |
3.556000E-01 |
| Stage2-vs-Stage3 |
9.807200E-01 |
| Stage2-vs-Stage4 |
7.696600E-01 |
| Stage3-vs-Stage4 |
7.221400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.48252546192407E-12 |
| Normal-vs-AfricanAmerican |
9.37830035852016E-10 |
| Normal-vs-Asian |
7.180500E-04 |
| Caucasian-vs-AfricanAmerican |
9.318000E-01 |
| Caucasian-vs-Asian |
8.934200E-01 |
| AfricanAmerican-vs-Asian |
8.674200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82198700571234E-12 |
| Normal-vs-Female |
5.79250000000142E-05 |
| Male-vs-Female |
3.221800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.0467000000044E-05 |
| Normal-vs-Extreme_Weight |
1.38300482177556E-12 |
| Normal-vs-Obese |
1.04690001112573E-09 |
| Normal-vs-Extreme_Obese |
1.902669999998E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.140600E-01 |
| Normal_Weight-vs-Obese |
7.679200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.987800E-01 |
| Extreme_Weight-vs-Obese |
3.090400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.420600E-01 |
| Obese-vs-Extreme_Obese |
7.457200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.604400E-04 |
| Normal-vs-Age(41-60Yrs) |
5.59470003658191E-09 |
| Normal-vs-Age(61-80Yrs) |
2.90878432451791E-14 |
| Normal-vs-Age(81-100Yrs) |
5.54840000055457E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.084600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.292300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.342640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.083400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.677000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.358800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.39759340054025E-13 |
| Normal-VS-Type2 PRCC |
2.79690000049015E-08 |
| Normal-VS-KIRP CIMP |
9.961700E-03 |
| Normal-VS-Unclassified PRCC |
5.58720000000124E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.550600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.487900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.021040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.612400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.323400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.472600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.43950423697947E-11 |
| Normal-vs-N1 |
1.923980E-02 |
| Normal-vs-N2 |
1.665770E-02 |
| N0-vs-N1 |
4.278100E-02 |
| N0-vs-N2 |
4.251000E-01 |
| N1-vs-N2 |
7.220200E-01 |
|
|
